Obesity Augments Glucocorticoid-Dependent Muscle Atrophy in Male C57BL/6J Mice.
Laura C GunderInnocence HarveyJeAnna R ReddCarol S DavisAyat Al-TamimiSusan V BrooksDave E BridgesPublished in: Biomedicines (2020)
Glucocorticoids promote muscle atrophy by inducing a class of proteins called atrogenes, resulting in reductions in muscle size and strength. In this work, we evaluated whether a mouse model with pre-existing diet-induced obesity had altered glucocorticoid responsiveness. We observed that all animals treated with the synthetic glucocorticoid dexamethasone had reduced strength, but that obesity exacerbated this effect. These changes were concordant with more pronounced reductions in muscle size, particularly in Type II muscle fibers, and potentiated induction of atrogene expression in the obese mice relative to lean mice. Furthermore, we show that the reductions in lean mass do not fully account for the dexamethasone-induced insulin resistance observed in these mice. Together, these data suggest that obesity potentiates glucocorticoid-induced muscle atrophy.
Keyphrases
- high fat diet induced
- insulin resistance
- skeletal muscle
- metabolic syndrome
- type diabetes
- weight loss
- mouse model
- adipose tissue
- high fat diet
- weight gain
- polycystic ovary syndrome
- high dose
- high glucose
- body mass index
- physical activity
- poor prognosis
- bone mineral density
- machine learning
- electronic health record
- long non coding rna
- drug induced